Mitsui & Co. invests additional $CDN25 billion in BioAmber Sarnia
BioAmber announced that Mitsui & Co., its partner in the Sarnia bio-based succinic acid plant, is investing an additional CDN$25 million in the joint venture for 10% of the equity, increasing its stake from 30% to 40%. BioAmber will maintain a 60% controlling stake in the joint venture. February 10, 2016